WebNov 17, 2024 · DICERNA PHARMACEUTICALS, INC., a Delaware corporation . Dated as of November 17, 2024 . Table of Contents . Section 1 . THE OFFER . 1.1 : The Offer : 2 : 1.2 ... Purchaser shall commence a tender offer (as it may be amended from time to time as permitted under this Agreement, ... WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiovascular, and viral infectious diseases in the United States and internationally. ... Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire ...
EX-2.1 - SEC
WebJan 2, 2024 · LEXINGTON, Mass.–(BUSINESS WIRE)–Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2024, has been completed.Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of … WebDec 8, 2024 · Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. ... Dicerna Pharmaceuticals, Inc., et al., Case No. 1:21-cv-10379 ... how to run a meat raffle fundraiser
Form SC 14D9/A Dicerna Pharmaceuticals Filed by: Dicerna ...
WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiovascular, and viral infectious … WebDec 9, 2024 · Subject: Dicerna Pharmaceuticals, Inc. – Tender Offer Option Symbol: DRNA Date: 12/22/21 Dicerna Pharmaceuticals, Inc. (DRNA) is the subject of an Offer … WebUnder the terms of the agreement, Novo Nordisk, through a subsidiary, will initiate a tender offer to acquire all outstanding shares of Dicerna common stock at a price of $38.25 per … northern nsw area health service